27 May 2026
Asahi Kasei Life Science licenses Noguchi Institute’s precision ADC technology
Novel ADC modality enables precise DAR and attachment-site control for single- and dual-payload ADCs, improving predictability of efficacy/safety; will be commercialized and co-developed.
